98 related articles for article (PubMed ID: 27001230)
1. Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance.
Lucafò M; Bravin V; Tommasini A; Martelossi S; Rabach I; Ventura A; Decorti G; De Iudicibus S
Clin Exp Pharmacol Physiol; 2016 Jun; 43(6):602-5. PubMed ID: 27001230
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA GAS5: a novel marker involved in glucocorticoid response.
Lucafo M; De Iudicibus S; Di Silvestre A; Pelin M; Candussio L; Martelossi S; Tommasini A; Piscianz E; Ventura A; Decorti G
Curr Mol Med; 2015; 15(1):94-9. PubMed ID: 25601472
[TBL] [Abstract][Full Text] [Related]
3. Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease.
Lucafò M; Di Silvestre A; Romano M; Avian A; Antonelli R; Martelossi S; Naviglio S; Tommasini A; Stocco G; Ventura A; Decorti G; De Iudicibus S
Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):87-93. PubMed ID: 28722800
[TBL] [Abstract][Full Text] [Related]
4. miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway.
Lucafò M; Sicari D; Chicco A; Curci D; Bellazzo A; Di Silvestre A; Pegolo C; Autry R; Cecchin E; De Iudicibus S; Collavin L; Evans W; Decorti G; Stocco G
Cancer Chemother Pharmacol; 2020 Sep; 86(3):361-374. PubMed ID: 32776229
[TBL] [Abstract][Full Text] [Related]
5. An Oncolytic Adenovirus Expressing SNORD44 and GAS5 Exhibits Antitumor Effect in Colorectal Cancer Cells.
Yuan S; Wu Y; Wang Y; Chen J; Chu L
Hum Gene Ther; 2017 Aug; 28(8):690-700. PubMed ID: 28530127
[TBL] [Abstract][Full Text] [Related]
6. Role of GAS5 noncoding RNA in mediating the effects of rapamycin and its analogues on mantle cell lymphoma cells.
Mourtada-Maarabouni M; Williams GT
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):468-73. PubMed ID: 24703244
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D interferes with glucocorticoid responsiveness in human peripheral blood mononuclear target cells.
Kassi E; Nasiri-Ansari N; Spilioti E; Kalotychou V; Apostolou PE; Moutsatsou P; Papavassiliou AG
Cell Mol Life Sci; 2016 Nov; 73(22):4341-4354. PubMed ID: 27220430
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid induces human beta cell dysfunction by involving riborepressor GAS5 LincRNA.
Esguerra JLS; Ofori JK; Nagao M; Shuto Y; Karagiannopoulos A; Fadista J; Sugihara H; Groop L; Eliasson L
Mol Metab; 2020 Feb; 32():160-167. PubMed ID: 32029226
[TBL] [Abstract][Full Text] [Related]
9. The effect of methylprednisolone on proliferation of PBMCs obtained from steroid-sensitive and steroid-resistant rheumatoid arthritis patients.
Sliwinska-Stanczyk P; Pazdur J; Ziolkowska M; Jaworski J; Kaminska-Tchorzewska E; Lacki JK
Scand J Rheumatol; 2007; 36(3):167-71. PubMed ID: 17657668
[TBL] [Abstract][Full Text] [Related]
10. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
[TBL] [Abstract][Full Text] [Related]
11. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.
Li Y; Gu J; Lu H
Dig Dis Sci; 2017 Dec; 62(12):3426-3437. PubMed ID: 29098549
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma.
Zhang H; Guo Y; Song Y; Shang C
Cancer Chemother Pharmacol; 2017 Jan; 79(1):49-55. PubMed ID: 27878359
[TBL] [Abstract][Full Text] [Related]
13. Plasma Long Non-Coding RNA (lncRNA) GAS5 is a New Biomarker for Coronary Artery Disease.
Yin Q; Wu A; Liu M
Med Sci Monit; 2017 Dec; 23():6042-6048. PubMed ID: 29267258
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer.
Li J; Huang H; Li Y; Li L; Hou W; You Z
Oncol Rep; 2016 Dec; 36(6):3241-3250. PubMed ID: 27779700
[TBL] [Abstract][Full Text] [Related]
16. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.
Han L; Ma P; Liu SM; Zhou X
Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
Cao S; Liu W; Li F; Zhao W; Qin C
Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
[TBL] [Abstract][Full Text] [Related]
18. Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosisnon-small cell lung cancer, long non-coding RNA, plasma, GAS5, biomarker.
Tan Q; Zuo J; Qiu S; Yu Y; Zhou H; Li N; Wang H; Liang C; Yu M; Tu J
Int J Oncol; 2017 May; 50(5):1729-1738. PubMed ID: 28339045
[TBL] [Abstract][Full Text] [Related]
19. LncRNA GAS5 positively regulates IL-10 expression in patients with generalized myasthenia gravis.
Peng S; Huang Y
Brain Behav; 2022 Jan; 12(1):e2457. PubMed ID: 34936242
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA-GAS5: A Novel Regulator of Hypertension-Induced Vascular Remodeling.
Wang YN; Shan K; Yao MD; Yao J; Wang JJ; Li X; Liu B; Zhang YY; Ji Y; Jiang Q; Yan B
Hypertension; 2016 Sep; 68(3):736-48. PubMed ID: 27432865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
